Marketing

  • A sign bearing the logo for the Centers for Disease Control and Prevention stands outside of an office building.
    Image attribution tooltip
    Elijah Nouvelage via Getty Images
    Image attribution tooltip
    Vaccines

    CDC panel to discuss COVID, hepatitis B shots in meeting next month

    A federal register notice confirmed dates for the anticipated advisory meeting, which will follow an FDA decision to narrow COVID boosters' approval and comes as CDC leadership is in turmoil.

    By • Aug. 28, 2025
  • Robert F. Kennedy Jr. in a blue stripe suit points while speaking
    Image attribution tooltip
    Andrew Harnik via Getty Images
    Image attribution tooltip

    MAHA may take aim at pharma DTC ads

    RFK Jr. has his sights set on increasing oversight and enforcement against drugmakers that run afoul of advertising laws.

    By Amy Baxter • Aug. 20, 2025
  • A stylized illustration of a pill breaking apart into smaller pills. Explore the Trendline➔
    Image attribution tooltip
    Brian Tucker / BioPharma Dive/BioPharma Dive
    Image attribution tooltip
    Trendline

    Commercialization

    New drugs for obesity and Alzheimer’s look set to become blockbusters, reshaping pharma marketing strategies just as many current top-sellers near looming patent cliffs.

    By BioPharma Dive staff
  • Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. testifies before the House Energy and Commerce Committee Health Subcommittee in the Rayburn House Office Building on June 24, 2025 in Washington, DC.
    Image attribution tooltip
    Kayla Bartkowski / Staff via Getty Images
    Image attribution tooltip
    Vaccines

    HHS revives defunct task force on childhood vaccine safety

    The panel’s reinstatement is one of a series of controversial moves made by Robert F. Kennedy Jr. to put vaccines under new scrutiny.

    By • Aug. 15, 2025
  • A photo of CureVac headquarters in Tuebingen, Germany
    Image attribution tooltip
    Courtesy of CureVac AG
    Image attribution tooltip
    Vaccines

    BioNTech ends patent fight with mRNA rival CureVac ahead of buyout deal

    The complex settlement, which hands payouts and royalties to CureVac and partner GSK, comes as BioNTech is inching toward an acquisition of its one-time COVID-19 vaccine competitor.

    By • Aug. 8, 2025
  • Close-up view of the Novo Nordisk logo mounted on the exterior wall of a building. The logo features a stylized blue Apis bull with a sun disk above its head, symbolizing the company's identity. The background shows a tan brick wall and part of a leafless tree in the foreground under a clear blue sky."
    Image attribution tooltip
    Alamy
    Image attribution tooltip
    Obesity drugs

    Novo pushes back against obesity drug compounders as competition intensifies

    The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its slipping position in the lucrative market for weight loss drugs.

    By • Aug. 6, 2025
  • A sign bearing the logo for the Centers for Disease Control and Prevention stands outside of an office building.
    Image attribution tooltip
    Elijah Nouvelage via Getty Images
    Image attribution tooltip
    Vaccines

    Experts ousted from CDC panel warn of damage to US vaccine policy

    The 17 advisers fired in June by Robert F. Kennedy Jr. urged alternatives to ACIP be organized to limit further degradation in vaccine guidelines.

    By • July 31, 2025
  • An Alnylam logo is displayed on a building in Cambridge, Massachusetts, on Sept. 5, 2024.
    Image attribution tooltip
    Jacob Bell/BioPharma Dive
    Image attribution tooltip

    Alnylam reaches new highs on strong sales of closely watched rare disease drug

    Despite battling drugs from BridgeBio and Pfizer, Amvuttra beat Wall Street expectations with results Alnylam’s CEO claimed were “not a flash in the pan.”

    By • July 31, 2025
  • A person seated in an armchair looks up at another in this still image taken from a video commercial.
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    J&J tests direct CAR-T marketing with first Carvykti ad

    The new direct-to-consumer ad signals J&J’s confidence in its capacity to meet demand for the cell therapy after earlier manufacturing struggles.

    By • Updated July 30, 2025
  • Kisunla, Eli Lilly
    Image attribution tooltip
    Permission granted by Eli Lilly
    Image attribution tooltip
    Brain drug revival

    In reversal, European regulators take positive view on Lilly Alzheimer’s drug

    Lilly’s appeal of an earlier, negative recommendation from a key EMA committee has worked out in its favor, and puts the drug, Kisunla, one step closer to European market entry.

    By • July 25, 2025
  • U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. testifies before the Senate Committee on Health, Education, Labor, and Pensions on Capitol Hill on May 14, 2025 in Washington, DC.
    Image attribution tooltip
    Anna Moneymaker / Staff via Getty Images
    Image attribution tooltip
    Vaccines

    RFK Jr. adopts CDC panel recommendation to remove thimerosal from flu shots

    The action will remove from use the very few flu shots that contain the contested preservative, elevating unproven fears it poses health risks.

    By • July 23, 2025
  • A photo of Bristol Myers Squibb and Pfizer's anticoagulant drug Eliquis
    Image attribution tooltip
    Scott Olson / Staff via Getty Images
    Image attribution tooltip

    Bristol Myers, Pfizer to offer Eliquis at a discount for some patients

    The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who aren’t insured or are willing to pay cash for their medications. 

    By • July 17, 2025
  • Bottles and cartons of prescription medicines are arranged on shelves.
    Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip

    Soleno sales of new Prader-Willi drug rise faster than expected

    Preliminary quarterly sales figures for Vykat surpassed Wall Street estimates, but shares fell on concerns the company may not be courting a buyer.

    By • July 10, 2025
  • A 3D illustration showing amyloid plaques in brain tissue
    Image attribution tooltip
    Dr_Microbe via Getty Images
    Image attribution tooltip

    Lilly gets FDA OK of modified dosing for Alzheimer’s drug

    A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to prescribe Lilly’s amyloid-busting drug.

    By • July 9, 2025
  • A person in a blue pinstripe suit looks straight ahead.
    Image attribution tooltip
    Andrew Harnik via Getty Images
    Image attribution tooltip
    Trump administration

    Medical groups, pregnant doctor sue RFK Jr. over vaccine changes

    The complaint argues Kennedy’s actions to remove the COVID vaccine from the CDC's immunization schedule for pregnant people and healthy children were unlawful.

    By • Updated July 8, 2025
  • A sign for Acadia Pharmaceuticals is seen on the side of an office building.
    Image attribution tooltip
    Permission granted by Acadia Pharmaceuticals
    Image attribution tooltip
    Q&A // Brain drug revival

    Acadia CEO sets sights on ‘much more assertive’ deals to invigorate pipeline

    Industry veteran Catherine Owen Adams expects external innovation will be key to getting the brain-focused drug developer to “the next level.”

    By • July 2, 2025
  • Modern glass window office building facade with the logo of Bristol Myers Squibb.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    FDA takes major step to ease access to CAR-T therapy

    The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ post-treatment movement.

    By • June 27, 2025
  • The exterior of the Supreme Court of the United States in Washington, D.C.
    Image attribution tooltip
    Chip Somodevilla via Getty Images
    Image attribution tooltip

    Supreme Court upholds ACA preventive services mandate

    The high court preserved a key part of the Affordable Care Act requiring private insurers cover a range of preventive healthcare services without cost sharing.

    By Emily Olsen • June 27, 2025
  • A man exits the front of the U.S. Capitol at dawn.
    Image attribution tooltip
    Win McNamee via Getty Images
    Image attribution tooltip

    Congress should reconsider breaking up PBMs, experts say

    Many proposals to reform the PBM industry miss the forest for the trees, experts said this week. Instead, Congress should go after the oligopoly enjoyed by the “Big Three” companies.

    By Rebecca Pifer • June 27, 2025
  • A person in a business suit sits at a desk in front of a microphone.
    Image attribution tooltip
    Elijah Nouvelage via Getty Images
    Image attribution tooltip
    Vaccines

    RFK Jr.-appointed panel recommends flu shots be free of contested preservative

    Thimerosal, targeted by activists who claim it’s linked to autism, shouldn't be used in vaccines given in the U.S. this coming flu season, the CDC panel said.

    By • Updated June 27, 2025
  • A person in a business suit listens to a presentation while sitting at a desk.
    Image attribution tooltip
    Elijah Nouvelage via Getty Images
    Image attribution tooltip

    Recast CDC panel recommends new RSV antibody for infants

    By a 5-2 vote, the Advisory Committee on Immunization Practices endorsed Merck’s Enflonsia for babies born during or entering their first RSV season.

    By • June 26, 2025
  • Boxes bearing the brand name Wegovy are arranged on a table.
    Image attribution tooltip
    Scott Olson via Getty Images
    Image attribution tooltip
    Obesity drugs

    Novo abruptly ends obesity drug deal with Hims

    The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo resolved its shortage.

    By • Updated June 23, 2025
  • U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. testifies before the Senate Committee on Health, Education, Labor, and Pensions on Capitol Hill on May 14, 2025 in Washington, DC.
    Image attribution tooltip
    Anna Moneymaker / Staff via Getty Images
    Image attribution tooltip
    Vaccines

    RFK Jr. reveals picks for influential vaccine panel

    Days after firing all 17 members of the CDC's Advisory Committee for Immunization Practices, the HHS Secretary named a small new committee that includes multiple vaccine critics.

    By Kristin Jensen • June 12, 2025
  • Illustration of lung cancer
    Image attribution tooltip
    SciePro via Getty Images
    Image attribution tooltip

    FDA clears Nuvation lung cancer drug, setting up battle with Bristol Myers and Roche

    The drug, Ibtrozi, will now vie for market share in an indication where multiple large pharmaceutical companies have already struggled to grow sales.

    By • June 11, 2025
  • Enhertu
    Image attribution tooltip
    Permission granted by Daiichi Sankyo
    Image attribution tooltip
    ASCO25

    AI tool could help doctors ID breast cancers vulnerable to Enhertu

    Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New research shows AI can improve diagnosis.

    By • May 22, 2025
  • Gavel sitting on cash
    Image attribution tooltip
    Avosb via Getty Images
    Image attribution tooltip

    Judge shuts down drugmakers’ 340B rebate plans, for now

    A district court ruled HHS has the power to review drugmakers’ plans to pay hospitals rebates on 340B medications. But it left the door open to the controversial reforms.

    By Rebecca Pifer • May 19, 2025